News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Epigenomics AG And Roche (RHHBY) Diagnostics Extend R&D Collaboration Agreement



10/19/2005 5:13:08 PM

Berlin, Germany and Seattle, WA, USA - September 30, 2005 lll Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today announced an extension to its existing agreement with Roche Diagnostics, a world leader in molecular diagnostics. The R&D part of the collaboration, which covers the development of five cancer diagnostic tests, has been extended for a minimum of 6 months, with the option to prolong and potentially expand for another 18 months. Financial terms were not disclosed.

Read at Hugin


comments powered by Disqus
Hugin
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES